AGP Executive Report
Last update: 28 minutes agoEbola Update: WHO says Bundibugyo Ebola is still not under control: cases fell in Ituri (-26%) and Haut Uele (-15%) over 21 days, but North Kivu jumped (+73%), with many new infections only identified after people die outside treatment centres. Vaccination Drive: DRC expanded Ervebo vaccination to Ituri, with MSF launching the BRAVO study in Bunia to follow about 20,000 frontline workers and test protection against Bundibugyo. Research Funding: CEPI pledged $3.9M for DRC and Uganda to strengthen surveillance, lab work, genomics, and modelling for Bundibugyo response and vaccine trial readiness. Mpox Lab Warning: Swiss-led research in The Lancet Infectious Diseases found nearly 35% of “PCR-positive” mpox tests in DRC cities may reflect contamination, raising the risk of false diagnoses. Conflict & Minerals: Amnesty reports M23 abuses against artisanal miners and trafficking of gold and coltan to Rwanda, warning of possible war crimes. Digital Payments: Visa named Fally Ipupa as brand ambassador for Visa Pay in the DRC, pushing the Central Bank’s cashless agenda. AI Influence: Anthropic says an AI-linked network used Claude to generate pro-government content tied to DRC-Rwanda tensions.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.